PDCD1LG2 (programmed cell death 1 ligand 2)

2006-10-01  

Identity

HGNC
LOCATION
9p24.1
LOCUSID
ALIAS
B7DC,Btdc,CD273,PD-L2,PDCD1L2,PDL2,bA574F11.2
FUSION GENES

Other Information

Locus ID:

NCBI: 80380
MIM: 605723
HGNC: 18731
Ensembl: ENSG00000197646

Variants:

dbSNP: 80380
ClinVar: 80380
TCGA: ENSG00000197646
COSMIC: PDCD1LG2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000197646ENST00000397747Q9BQ51

Expression (GTEx)

0
5
10
15

Pathways

PathwaySourceExternal ID
Cell adhesion molecules (CAMs)KEGGko04514
Cell adhesion molecules (CAMs)KEGGhsa04514
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Costimulation by the CD28 familyREACTOMER-HSA-388841
PD-1 signalingREACTOMER-HSA-389948

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
389567242024Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunity.0
389567242024Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunity.0
354667592023The Overexpression of Programmed Death-Ligand 2 in Uterine Adenosarcoma: Correlation with High-Grade Morphology, Mutant Type TP53 Expression and Clinical Outcomes.2
362817602023Programmed cell death 1 and programmed cell death ligand 1 expression in invasive breast carcinoma using CAL10 and NAT105 immunostaining.0
365224742023Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy.24
366562072023PD-L1 and PD-L2 expression in colorectal cancer.1
368306092023Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases.0
370062392023Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment.4
370608832023The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.1
371464142023PD-L1 and PD-L2 immune checkpoint protein induction by type III interferon in non-small cell lung cancer cells.3
374020542023PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma.1
377683452023An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response.1
378284292023Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines.3
354667592023The Overexpression of Programmed Death-Ligand 2 in Uterine Adenosarcoma: Correlation with High-Grade Morphology, Mutant Type TP53 Expression and Clinical Outcomes.2
362817602023Programmed cell death 1 and programmed cell death ligand 1 expression in invasive breast carcinoma using CAL10 and NAT105 immunostaining.0

Citation

Dessen P

PDCD1LG2 (programmed cell death 1 ligand 2)

Atlas Genet Cytogenet Oncol Haematol. 2006-10-01

Online version: http://atlasgeneticsoncology.org/gene/43401/js/lib/tumors-explorer/humanGenome